IL4I1 and neoplasm: Similarly, IL4I1-deficient mice challenged with chronic lymphocytic leukemia present with reduced tumor burden, which is accompanied by enhanced CD8+ T-cell functionality and reduced frequency of total and activated regulatory T cells (37).